ClinicalTrials.Veeva

Menu

A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study

T

Ting Huang

Status

Completed

Conditions

Deep Learning
Tumor Grading
Clear Cell Renal Cell Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT06559046
2024107

Details and patient eligibility

About

This study aims to establish an effective deep learning model to extract relevant information about renal tumors and kidneys from computed tomography (CT) images and predict the pathological grades of clear cell renal cell carcinoma (ccRCC).

Retrospective data were collected from 483 ccRCC patients across three medical centers. Arterial phase and portal venous phase CT images from the dataset were segmented for renal tumors and kidneys. Three convolutional neural networks (CNNs) were employed to extract features from the regions of interest (ROI) in the CT images across multiple dimensions including 3D, 2.5D, and 2D. Least absolute shrinkage and selection (LASSO) regression was used for feature selection. The models were evaluated using receiver operating characteristic (ROC) curves and decision curve analysis (DCA).

Enrollment

483 patients

Sex

All

Ages

30 to 88 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with a single kidney tumor have complete imaging and clinical data
  • Contrast-enhanced CT scan within 30 days before surgery
  • No treatment was performed before CT examination

Exclusion criteria

  • Patients with tumor recurrence
  • Obvious artifacts on CT images
  • The tumor is cystic
  • Multiple cysts on the affected kidney affect the delineation of renal parenchyma

Trial design

483 participants in 2 patient groups

High grade
Low grade

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems